Targeting the Hedgehog signaling pathway for cancer therapy

Bibliography

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300
   PubMed Web of Science ®Google Scholar
• Woll PS, Morris JK, Painschab MS, Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 2008;111:122-31
   PubMed Web of Science ®Google Scholar
• Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 2010;16:3153-62
   PubMed Web of Science ®Google Scholar
• Merchant A, Joseph G, Wang Q, Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010;115:2391-6
   PubMed Web of Science ®Google Scholar
• Varnat F, Duquet A, Malerba M, Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009;1:338-51
   PubMed Web of Science ®Google Scholar
• Syn WK, Jung Y, Omenetti A, Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology 2009;137:1478-88
   PubMed Web of Science ®Google Scholar
• Malizia AP, Lacey N, Walls D, CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells. Exp Cell Res 2009;315:1819-31
   Google Scholar
• Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-80
   PubMed Web of Science ®Google Scholar
• Khan N, Afaq F, Mukhtar H. Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis 2007;28:233-9
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Cotroneo MS, Fritz WA, Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 2002;132:552S-8S
   PubMed Web of Science ®Google Scholar
• Li Y, Sarkar FH. Gene expression profiles of genistein-treated PC3 prostate cancer cells. J Nutr 2002;132:3623-31
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Sarkar FH. Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 2003;133:1011-19
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001;20:7597-609
   PubMed Web of Science ®Google Scholar
• Gupta S, Hussain T, Mukhtar H. Molecular pathway for (–)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003;410:177-85
   PubMed Web of Science ®Google Scholar
• Gritli-Linde A, Bei M, Maas R, Shh signaling within the dental epithelium is necessary for cell proliferation, growth and polarization. Development 2002;129:5323-37
   PubMed Web of Science ®Google Scholar
• Yang L, Xie G, Fan Q, Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010;29:469-81
   PubMed Web of Science ®Google Scholar
• Osterlund T, Kogerman P. Hedgehog signalling: how to get from Smo to Ci and Gli. Trends Cell Biol 2006;16:176-80
   PubMed Web of Science ®Google Scholar
• Nagase T, Nagase M, Machida M, Hedgehog signaling: a biophysical or biomechanical modulator in embryonic development? Ann NY Acad Sci 2007;1101:412-38
   Google Scholar
• Eggenschwiler JT, Anderson KV. Cilia and developmental signaling. Annu Rev Cell Dev Biol 2007;23:345-73
   PubMed Web of Science ®Google Scholar
• Bale AE. Hedgehog signaling and human disease. Annu Rev Genomics Hum Genet 2002;3:47-65
   PubMedGoogle Scholar
• Taipale J, Cooper MK, Maiti T, Patched acts catalytically to suppress the activity of Smoothened. Nature 2002;418:892-7
   PubMed Web of Science ®Google Scholar
• Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol 2002;12:523-31
   PubMed Web of Science ®Google Scholar
• Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 2001;11:547-53
   PubMed Web of Science ®Google Scholar
• Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001;15:3059-87
   PubMed Web of Science ®Google Scholar
• Price MA, Kalderon D. Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell 2002;108:823-35
   PubMed Web of Science ®Google Scholar
• Cohen MM Jr. The hedgehog signaling network. Am J Med Genet A 2003;123A:5-28
   PubMed Web of Science ®Google Scholar
• Chen Y, Yue S, Xie L, Dual Phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium. J Biol Chem 2011;286:13502-11
   PubMed Web of Science ®Google Scholar
• Yang SH, Andl T, Grachtchouk V, Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta3-catenin signaling. Nat Genet 2008;40:1130-5
   PubMed Web of Science ®Google Scholar
• Androutsellis-Theotokis A, Leker RR, Soldner F, Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006;442:823-6
   PubMed Web of Science ®Google Scholar
• Ingram WJ, McCue KI, Tran TH, Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling. Oncogene 2008;27:1489-500
   PubMed Web of Science ®Google Scholar
• Zhao X, Malhotra GK, Lele SM, Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proc Natl Acad Sci USA 2010;107:14146-51
   PubMed Web of Science ®Google Scholar
• Day TF, Yang Y. Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am 2008;90(Suppl 1):19-24
   Google Scholar
• Fuxe J, Vincent T, Garcia de HA. Transcriptional crosstalk between TGFbeta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010;9:2363-74
   PubMed Web of Science ®Google Scholar
• Johnson RW, Nguyen MP, Padalecki SS, TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res 2011;71:822-31
   PubMed Web of Science ®Google Scholar
• Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008;22:2454-72
   PubMed Web of Science ®Google Scholar
• Medina V, Calvo MB, az-Prado S, Hedgehog signalling as a target in cancer stem cells. Clin Transl Oncol 2009;11:199-207
   PubMedGoogle Scholar
• Caro I, Low JA. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010;16:3335-9
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen M, Lu Y, A novel mutation of the PTCH1 gene activates the Shh/Gli signaling pathway in a Chinese family with nevoid basal cell carcinoma syndrome. Biochem Biophys Res Commun 2011;409:166-70
   Google Scholar
• Fujii M, Noguchi K, Urade M, Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma. J Hum Genet 2011;56:277-83
   Google Scholar
• Ji J, Kump E, Wernli M, Gene silencing of transcription factor Gli2 inhibits basal cell carcinomalike tumor growth in vivo. Int J Cancer 2008;122:50-6
   Web of Science ®Google Scholar
• Inaguma S, Kasai K, Ikeda H. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 2011;30:714-23
   Google Scholar
• Dai J, Ai K, Du Y, Sonic hedgehog expression correlates with distant metastasis in pancreatic adenocarcinoma. Pancreas 2011;40:233-6
   PubMed Web of Science ®Google Scholar
• Quint K, Stintzing S, Alinger B, The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology 2009;9:116-26
   PubMed Web of Science ®Google Scholar
• Walter K, Omura N, Hong SM, Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res 2010;16:1781-9
   Google Scholar
• Kelleher FC. Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis 2011;32:445-51
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-61
   PubMed Web of Science ®Google Scholar
• Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Promotion of the self-renewal capacity of human leukemia cells by sonic hedgehog protein. Anticancer Res 2011;31:781-4
   PubMed Web of Science ®Google Scholar
• Long B, Zhu H, Zhu C, Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients. J Exp Clin Cancer Res 2011;30:8
   PubMed Web of Science ®Google Scholar
• Jagani Z, Dorsch M, Warmuth M. Hedgehog pathway activation in chronic myeloid leukemia. Cell Cycle 2010;9:3449-56
   PubMed Web of Science ®Google Scholar
• Desch P, Asslaber D, Kern D, Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene 2010;29:4885-95
   PubMed Web of Science ®Google Scholar
• Singh RR, Kim JE, Davuluri Y, Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010;24:1025-36
   PubMed Web of Science ®Google Scholar
• Vezina CM, Bushman AW. Hedgehog signaling in prostate growth and benign prostate hyperplasia. Curr Urol Rep 2007;8:275-80
   Google Scholar
• Anton Aparicio LM, Garcia CR, Cassinello EJ, Prostate cancer and Hedgehog signalling pathway. Clin Transl Oncol 2007;9:420-8
   PubMed Web of Science ®Google Scholar
• Zhang J, Lipinski R, Shaw A, Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines. J Urol 2007;177:1179-85
   PubMedGoogle Scholar
• Souzaki M, Kubo M, Kai M, Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer. Cancer Sci 2011;102:373-81
   PubMed Web of Science ®Google Scholar
• Das S, Samant RS, Shevde LA. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J Biol Chem 2011;286:9612-22
   Google Scholar
• Varnat F, Duquet A, Malerba M, Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009;1:338-51
   PubMed Web of Science ®Google Scholar
• Choi SS, Omenetti A, Witek RP, Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 2009;297:G1093-106
   PubMed Web of Science ®Google Scholar
• Isohata N, Aoyagi K, Mabuchi T, Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer 2009;125:1212-21
   PubMed Web of Science ®Google Scholar
• Ohta H, Aoyagi K, Fukaya M, Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers. Br J Cancer 2009;100:389-98
   PubMed Web of Science ®Google Scholar
• Omenetti A, Porrello A, Jung Y, Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331-42
   PubMed Web of Science ®Google Scholar
• Maitah MY, Ali S, Ahmad A, Up-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011;6:e16068
   PubMed Web of Science ®Google Scholar
• Tian F, Mysliwietz J, Ellwart J, Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations. Clin Exp Med 2011; published online 26 April 2011; doi: 10.1007/s10238-011-0135-8
   Web of Science ®Google Scholar
• Ailles L, Siu LL. Targeting the hedgehog pathway in cancer: can the spines be smoothened? Clin Cancer Res 2011;17:2071-3
   Google Scholar
• Von Hoff DD, Lorusso PM, Rudin CM, Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72
   PubMed Web of Science ®Google Scholar
• Doggrell SA. The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opin Investig Drugs 2010;19:451-4
   PubMed Web of Science ®Google Scholar
• Amin SH, Tibes R, Kim JE, Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma. Laryngoscope 2010;120:2456-9
   PubMed Web of Science ®Google Scholar
• Lorusso PM, Rudin CM, Reddy JC, Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 2011;17:2502-11
   PubMed Web of Science ®Google Scholar
• De SE, Ferretti E, Gulino A. Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers. Curr Opin Investig Drugs 2010;11:707-18
   Google Scholar
• Rudin CM, Hann CL, Laterra J, Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-8
   PubMed Web of Science ®Google Scholar
• Yauch RL, Dijkgraaf GJ, Alicke B, Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009;326:572-4
   PubMed Web of Science ®Google Scholar
• Dijkgraaf GJ, Alicke B, Weinmann L, Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance. Cancer Res 2011;71:435-44
   PubMed Web of Science ®Google Scholar
• Skvara H, Kalthoff F, Meingassner JG, Topical treatment of basal cell carcinomas in nevoid basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol 2011;131:1735-44
   PubMed Web of Science ®Google Scholar
• Stuetz A, De Rie MA, Skvara H, LDE225, a specific smoothened inhibitor, for the topical treatment of nevoid basal cell carcinoma syndrome (Gorlin's syndrome). Melanoma Res 2010;20:e40
   Google Scholar
• Rodon Ahnert J, Baselga J, Tawbi HA, A phase I dose-escalation study of LDE225, a smoothened (Smo) antagonist, in patients with advanced solid tumors. J Clin Oncol 2010;28:2500
   Google Scholar
• Buonamici S, Williams J, Morrissey M, Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2010;2:51ra70
   PubMed Web of Science ®Google Scholar
• Lin TL, Wang QH, Brown P, Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS ONE 2010;5:e15262
   PubMed Web of Science ®Google Scholar
• Infinity Pharmaceuticals. A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer. ClinicalTrials.gov NCT01130142 Available from: http://clinicaltrials.gov/ct2/show/NCT01130142?term=NCT01130142&rank=1
   Google Scholar
• Infinity Pharmaceuticals. A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma. ClinicalTrials.gov NCT01310816 Available from: http://clinicaltrials.gov/ct2/show/NCT01310816?term=NCT01310816&rank=1
   Google Scholar
• Bristol-Myers Squibb. Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma. ClinicalTrials.gov NCT00884546 Available from: http://clinicaltrials.gov/ct2/show/NCT00884546?term=NCT00884546&rank=1
   Google Scholar
• Bristol-Myers Squibb. Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923). ClinicalTrials.gov NCT01357655 Available from: http://clinicaltrials.gov/ct2/show/NCT01357655?term=NCT01357655&rank=1
   Google Scholar
• Bristol-Myers Squibb. A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas. ClinicalTrials.gov NCT00909402 Available from: http://clinicaltrials.gov/ct2/show/NCT00909402?term=NCT00909402&rank=1
   Google Scholar
• Millennium Pharmaceuticals, Inc. A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies. ClinicalTrials.gov NCT01204073 Available from: http://clinicaltrials.gov/ct2/show/NCT01204073?term=NCT01204073&rank=1
   Google Scholar
• Pfizer. A Study Of PF-04449913 In Select Hematologic Malignancies Or With Dasatinib or Bosutinib In Chronic Myeloid Leukemia (CML). ClinicalTrials.gov NCT00953758 Available from: http://clinicaltrials.gov/ct2/show/NCT00953758?term=NCT00953758&rank=1
   Google Scholar
• Williams JA. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Drug News Perspect 2003;16:657-62
   PubMed Web of Science ®Google Scholar
• Williams JA, Guicherit OM, Zaharian BI, Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 2003;100:4616-21
   PubMed Web of Science ®Google Scholar
• Shi T, Mazumdar T, DeVecchio J, cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One 2010;5: published online 1 October 2010; doi:10.1371/journal.pone.0013054
   Google Scholar
• Mazumdar T, DeVecchio J, Shi T, Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res 2011;71:1092-102
   PubMed Web of Science ®Google Scholar
• Yan M, Wang L, Zuo H, HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma. Oral Oncol 2011;47:504-9
   Google Scholar
• Mechlin CW, Tanner MJ, Chen M, Gli2 expression and human bladder transitional carcinoma cell invasiveness. J Urol 2010;184:344-51
   Google Scholar
• Guan CC, Yan M, Jiang XQ, Sonic hedgehog alleviates the inhibitory effects of high glucose on the osteoblastic differentiation of bone marrow stromal cells. Bone 2009;45:1146-52
   Google Scholar
• Tostar U, Toftgard R, Zaphiropoulos PG, Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway. Genes Cancer 2010;1:941-51
   Google Scholar
• Kawabata N, Ijiri K, Ishidou Y, Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth. Int J Oncol 2011;39:899-906
   Google Scholar
• Novartis Pharmaceuticals. A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors. ClinicalTrials.gov NCT01106508 Available from: http://clinicaltrials.gov/ct2/show/NCT01106508?term=NCT01106508&rank=1
   Google Scholar
• Adlercreutz H, Honjo H, Higashi A, Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991;54:1093-100
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-10
   PubMed Web of Science ®Google Scholar
• Hebert JR, Hurley TG, Olendzki BC, Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 1998;90:1637-47
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 1998;9:553-7
   PubMed Web of Science ®Google Scholar
• Slusarz A, Shenouda NS, Sakla MS, Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res 2010;70:3382-90
   PubMed Web of Science ®Google Scholar
• Miquel J, Bernd A, Sempere JM, The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 2002;34:37-46
   PubMed Web of Science ®Google Scholar
• Banerjee M, Tripathi LM, Srivastava VM, Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003;25:213-24
   PubMed Web of Science ®Google Scholar
• Elamin MH, Shinwari Z, Hendrayani SF, Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog 2010;49:302-14
   PubMed Web of Science ®Google Scholar
• Lim KJ, Bisht S, Bar EE, A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011;11:464-73
   PubMed Web of Science ®Google Scholar
• Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 2007;16(Suppl 1):453-7
   PubMed Web of Science ®Google Scholar
• Khan N, Adhami VM, Mukhtar H. Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer 2009;61:836-41
   PubMed Web of Science ®Google Scholar
• Tang GQ, Yan TQ, Guo W, (–)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J Cancer Res Clin Oncol 2010;136:1179-85
   PubMedGoogle Scholar
• Bove K, Lincoln DW, Tsan MF. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem Biophys Res Commun 2002;291:1001-5
   PubMed Web of Science ®Google Scholar
• Garland CF, Garland FC, Gorham ED, The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61
   PubMed Web of Science ®Google Scholar
• Pike JW, Meyer MB, Martowicz ML, Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2010;121:130-5
   Google Scholar
• Tang JY, Xiao TZ, Oda Y, Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Cancer Prev Res (Phila) 2011;4:744-51
   PubMed Web of Science ®Google Scholar
• Bijlsma MF, Peppelenbosch MP. Spek CA. (Pro-)vitamin D as treatment option for hedgehog-related malignancies. Med Hypotheses 2008;70:202-3
   PubMed Web of Science ®Google Scholar
• Tang JY, So PL, Epstein EH Jr. Novel Hedgehog pathway targets against basal cell carcinoma. Toxicol Appl Pharmacol 2007;224:257-64
   PubMed Web of Science ®Google Scholar
• Bruggemann LW, Queiroz KC, Zamani K, Assessing the efficacy of the hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer. Cancer Biol Ther 2010;10:79-88
   PubMed Web of Science ®Google Scholar
• Bijlsma MF, Spek CA, Zivkovic D, Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol 2006;4:e232
   PubMed Web of Science ®Google Scholar
• Rudin CM, Weiss GJ, Chang A, A Phase 1 Study of IPI-926, an Inhibitor of the Hedgehog Pathway, in Patients with Advanced or Metastatic Solid Tumors. Available from: http://infi.com/pipeline-archives/INFI_ESMO_2010.pdf. The data was presented in 2010 ESMO.
   Google Scholar